Drawing for STOCKHOLM3 PSA PLUS

USPTO serial 79454284

STOCKHOLM3 PSA PLUS

Reviewed by CopyMark Law Group

Status 640Office Action
Filing date
Status date
Registration date
—
Examiner
ORDOGNE, ROBERT J
Law office
TMO LAW OFFICE 126

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 640: Status 640 means the examining attorney has prepared a non-final Office Action but it has not been mailed or e-mailed yet. The action should appear in TSDR soon, and a response deadline will start once it is issued.

Need help with STOCKHOLM3 PSA PLUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic test reagents for medical purposes for prostate cancer testing; pharmaceutical preparations for treatment of cancer; reagents for use in diagnostic tests for medical purposes; diagnostic test materials for medical purposes; diagnostic preparations for medical purposes; diagnostic agents for medical use.ACTIVE—
009Downloadable software for calculating the risk of prostate cancer; downloadable computer programs for calculating the risk of prostate cancer; downloadable computer software for prostate cancer testing; downloadable application software for calculating the risk of prostate cancer; scientific research and laboratory apparatus for measuring, quantification and analysis of proteins and genetic material; medical training simulators for educational purposes in the field of prostate cancer; scientific research and laboratory instruments for detecting proteins and genetic material for medical research and training purposes; computer peripherals devices.ACTIVE—
010Medical instruments, namely, protein and genetic measuring instruments for medical diagnostic purposes; medical apparatus and instruments for the diagnosis, examination, monitoring and treatment of prostate cancer; medical testing apparatus and instruments for detecting and diagnosing prostate cancer; testing probes for medical diagnostic purposes; medical diagnostic tools for calculating prostate cancer risk.ACTIVE—
042IT integration services; computer software development, programming and implementation for others; website hosting services; software as a service (SaaS) featuring computer software for calculating prostate cancer risk scores; rental of computer software for use in calculating cancer risk; providing temporary use of online non-downloadable computer software for calculating prostate cancer risk scores; application service provider featuring computer software for calculating prostate cancer risk scores; scientific research and analysis in the field of prostate cancer; medical and pharmacological research services in the field of prostate cancer; conducting clinical trials for others in the field of prostate cancer; scientific and medical research in the field of oncology and urology; providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; providing information on clinical studies via an interactive website.ACTIVE—
044Human healthcare services, namely, disease management programs; medical services in the field of oncology and urology; medical diagnostic services in the field of oncology and urology; medical diagnostic testing services for prostate cancer; prostate cancer screening services; medical analysis services for the diagnosis and treatment of cancer and related diseases; providing online information services relating to medical and diagnostic tests, namely information regarding prostate cancer tests for diagnosis and treatment purposes; phlebotomy services; medical blood testing services; blood sampling and analysis for diagnostic or treatment purposes; providing medical information relating to prostate cancer test results; providing medical information relating to medical diagnostic test results; medical analysis services for diagnostic provided by medical laboratories; medical laboratory analysis services for the analysis of samples and blood samples taken from patients for diagnostic purposes; rental of medical equipment for use in human healthcare; medical consultancy services in the field of oncology and urology; providing medical information in the field of oncology and urology.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 12, 2026RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Jul 30, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 29, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2026DOCKASSIGNED TO EXAMINER—
Jul 17, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 17, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 16, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance